研究者
J-GLOBAL ID:201801001668644532   更新日: 2020年09月01日

荒川 泰弘

アラカワヤス ヒロ | Arakawa Yasuhiro
所属機関・部署:
論文 (28件):
  • Arakawa Y, Shirai Y, Hayashi K, Tanaka Y, Matsumoto A, Nishikawa K, Yano S. Effects of gene polymorphisms on the risk of severe hyponatremia during DCF chemotherapy for patients with esophageal squamous cell carcinoma. Oncology letters. 2018. 16. 4. 5455-5462
  • Kazumi Hayashi, Eijiro Nagasaki, Koji Nakada, Miho Tamura, Yasuhiro Arakawa, Tadashi Uwagawa, Shingo Yano. Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2. Journal of Infection and Chemotherapy. 2018. 24. 4. 298-301
  • Yasuhiro Arakawa, Miho Tamura, Keisuke Aiba, Kazuhiko Morikawa, Daisuke Aizawa, Masahiro Ikegami, Masami Yuda, Katsunori Nishikawa. Significant response to ramucirumab, monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report. ONCOLOGY LETTERS. 2017. 14. 3. 3039-3042
  • Kazuhito Suzuki, Kouhei Yamamoto, Yasuhiro Arakawa, Hisashi Yamada, Keisuke Aiba, Masanobu Kitagawa. Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL. ANTI-CANCER DRUGS. 2016. 27. 8. 756-765
  • Akira Matsumoto, Katsunori Nishikawa, Masami Yuda, Yujiro Tanaka, Yuichiro Tanishima, Yasuhiro Arakawa, Yoshio Ishibashi, Toshikazu Sakuyama, Nobuo Omura, Norio Mitsumori, et al. Early Response of Esophageal Cancer to Neoadjuvant Chemotherapy with Docetaxel-Cisplatin-5-Fluorouracil Represents Sensitivity: A Phase II Study. ANTICANCER RESEARCH. 2016. 36. 4. 1937-1942
もっと見る
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る